Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.40
-0.19 (-3.40%)
At close: Jun 26, 2026, 4:00 PM EDT
5.40
-0.01 (-0.09%)
After-hours: Jun 26, 2026, 4:10 PM EDT
IMDX Employees
As of December 31, 2025, Insight Molecular Diagnostics had 58 total employees, including 55 full-time and 3 part-time employees. The number of employees increased by 9 or 18.37% compared to the previous year.
Employees
58
Change (1Y)
9
Growth (1Y)
18.37%
Revenue / Employee
$33,603
Profits / Employee
-$824,845
Market Cap
174.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 942 |
| Burning Rock Biotech | 667 |
| MDxHealth | 364 |
| Biodesix | 334 |
| Personalis | 260 |
IMDX News
- 5 days ago - iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant - GlobeNewsWire
- 11 days ago - Favorable Head-to-Head Data on iMDx's GraftAssure with Competing NGS Assay Published in Clinical Chemistry - GlobeNewsWire
- 16 days ago - IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation - GlobeNewsWire
- 18 days ago - iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress - GlobeNewsWire
- 6 weeks ago - Insight Molecular Diagnostics Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Insight Molecular Diagnostics Earnings release: Q1 2026 - Filings
- 6 weeks ago - Insight Molecular Diagnostics Shareholder letter: Q1 2026 - Filings
- 6 weeks ago - Insight Molecular Diagnostics Quarterly report: Q1 2026 - Filings